GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Yanling,Feng

第一单位： 1. Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510080, China.

作者： Yanling,Feng ^[1] ; Fan,He ^[2] ; Huini,Wu ^[3] ; He,Huang ^[1] ; Lan,Zhang ^[1] ; Xian,Han ^[4] ; Jihong,Liu ^[1]

作者单位： 1. Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510080, China. ^[1] 2. Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. ^[2] 3. Department of Biology, University of Illinois at Chicago, Chicago, IL 60607, USA. ^[3] 4. Department of Forensic Medicine, Zhongshan Medical School, Sun Yat-Sen University, Guangzhou, Guangdong 510080, P.R. China. ^[4]

关键词 GOLPH3L epithelial ovarian cancer prognosis

DOI 10.7150/jca.11865

PMID 26284141

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览66

Journal of Cancer

2015年6卷9期

893-900页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer.

Journal of Cancer

相似文献

Journal of Cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer.

Journal of Cancer

相似文献

Journal of Cancer

相关期刊

检索历史清除